Sign up to save your podcasts
Or
Share Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Reduction in All-Cause Mortality with Fluticasone (FF/UMEC/VI) in COPD Patients
The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
View all episodes
By American Thoracic Society
4
3636 ratings
The article discussed in today's episode is Open Access and can be found here:
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
More shows like Out of the Blue: An AJRCCM Podcast
View all
EMCrit FOAM Feed
1,867 Listeners
JAMA Editors' Summary
137 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
498 Listeners
CHEST Journal Podcasts
64 Listeners
ATS Breathe Easy
36 Listeners
The Curbsiders Internal Medicine Podcast
3,357 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Annals On Call Podcast
191 Listeners
The Internet Book of Critical Care Podcast
696 Listeners
JAMA Medical News
93 Listeners
Run the List
248 Listeners
Critical Care Scenarios
258 Listeners
The Curious Clinicians
374 Listeners
Critical Care Time
268 Listeners